Cystatin C and acute changes in glomerular filtration rate

Area of Science:

• Nephrology
• Biomarker Discovery
• Renal Function Assessment

Background:

• Serum creatinine is the standard marker for glomerular filtration rate (GFR), but it can provide biased estimates of acute kidney function changes.
• Limitations of serum creatinine include non-glomerular clearance, potentially delaying the identification of acute kidney injury.
• Cystatin C (CysC) is emerging as a more sensitive marker for GFR, particularly in dynamic renal function scenarios.

Purpose of the Study:

• To review existing literature on short-term changes in CysC levels.
• To explore the clinical utility of CysC in assessing acute changes in kidney function.
• To evaluate CysC as a potential replacement or adjunct to serum creatinine for GFR estimation.

Main Methods:

• Literature review of controlled physiological and clinical studies.
• Analysis of studies involving diabetes, glomerular hyperfiltration, exercise, contrast-induced nephropathy, acute kidney injury, and kidney transplantation.
• Focus on CysC dynamics over short-term periods (days, weeks, months).

Main Results:

• Physiological studies indicate CysC changes better approximate GFR changes than serum creatinine in various conditions.
• Clinical studies suggest CysC offers advantages in accurately measuring GFR and early diagnosis of renal dysfunction.
• CysC measurements are associated with improved patient outcome prediction and prognosis.

Conclusions:

• Cystatin C demonstrates significant potential for improving the detection of acute kidney function changes.
• CysC may offer a more accurate and timely assessment of renal function compared to serum creatinine.
• Further clinical integration of CysC could enhance diagnostic capabilities in nephrology.